A recent study published in eBioMedicine sheds new light on the effects of lithium on circadian rest-activity patterns in individuals with bipolar disorder (BD), a chronic mental health condition marked by significant mood swings and disrupted activity levels. Researchers explored how lithium—a widely used treatment for BD—affects the 24-hour sleep-wake cycle, an internal process known as circadian rhythm. The study highlights promising changes in BD patients’ circadian cycles, which may offer new insights into how lithium helps stabilize mood disorders.
BD patients often experience unstable circadian rhythms, which are linked to more intense manic symptoms, delayed circadian phase, and increased mood variability. Despite lithium’s status as the gold-standard treatment for BD, its exact mechanisms of action remain unclear. Prior studies in animals and cell lines have suggested that lithium might influence circadian rhythms, but similar evidence in BD patients has been sparse. Notably, prior findings have indicated that lithium might promote an earlier wake time in BD patients, although existing studies have been limited by their cross-sectional design, which prevents drawing causal conclusions.
The study followed BD patients to examine lithium’s early impact on their circadian rest-activity patterns. A total of 35 adults diagnosed with BD were recruited from Oxford’s community mental health teams and primary care services. Participants were randomized to receive either lithium or a placebo over a six-week period. Individuals were excluded if they had contraindications to lithium, a history of substance abuse, suicidal ideation, or were pregnant or breastfeeding.
The treatment group received lithium carbonate at a starting dose of 400 mg/day, with adjustments made to maintain serum levels in the therapeutic range. During the intervention, participants were assessed for mood changes, treatment adherence, and any adverse effects. Circadian rest-activity was measured daily using actigraphy, a non-invasive technique that records physical movement patterns, and a number of statistical models were employed to analyze variability in activity levels.
The study found notable changes in circadian rest-activity following lithium treatment. Over the four-week treatment period, participants in the lithium group showed a significant reduction in daytime activity levels (M10) by 30.9% by week 4 compared to the placebo group. Additionally, lithium increased the variability or “volatility” of the patients’ activity levels, particularly during the first few weeks, suggesting an initial destabilization that might help patients transition toward more stable patterns in the long term. By the end of the study, participants who received lithium showed an earlier onset of activity (M10) by 1.5 to 1.6 hours in weeks 3 and 4.
Interestingly, this increased volatility was not directly linked to changes in mood, as there was no significant correlation between the reduction in M10 levels and fluctuations in M10 onset times. However, this increased flexibility could be seen as a beneficial shift, allowing for a more adaptable circadian rhythm, potentially leading to better long-term stability.
The study’s findings suggest that lithium treatment can cause significant changes in circadian rhythms in BD patients, particularly advancing daytime activity and increasing variability. Researchers interpret this increased volatility as a potential mechanism that might facilitate a shift toward healthier, more stable circadian patterns. While these changes could help explain lithium’s mood-stabilizing effects, the authors caution that further research with larger sample sizes and longer follow-up periods is needed to fully understand the relationship between circadian rhythms and lithium’s therapeutic action.
These results provide an intriguing look into how lithium may help regulate circadian rhythms in BD patients, offering valuable insights into its potential role in mood stabilization. As circadian changes could precede and even contribute to mood shifts, they may represent a key mechanism through which lithium exerts its therapeutic effects.
In conclusion, lithium appears to enhance circadian flexibility, advancing the timing of daytime activity, and contributing to the overall stabilization of mood in BD patients. The study opens the door for future research to explore the broader implications of these findings and their potential for improving BD treatment strategies.
You Might Be Interested In:
-
Adolescent Obesity in England Increases by 50% Over 15 Years, Study Reveals
-
WHO Leads Global Action On Maternal And Newborn Health For World Health Day
